EGX:MCRO Revenue

Macro Group Pharmaceuticals (Macro Capital) S.A.E had revenue of 184.39M EGP in the quarter ending March 31, 2025, with 209.71% growth. This brings the company's revenue in the last twelve months to 644.82M, up 49.84% year-over-year. In the year 2024, Macro Group Pharmaceuticals (Macro Capital) S.A.E had annual revenue of 519.97M, down -1.15%.

Revenue (ttm)

644.82M

Revenue Growth

+49.84%

P/S Ratio

1.85

Revenue / Employee

n/a

Employees

n/a

Market Cap

1.19B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	519.97M	-6.04M	-1.15%
Dec 31, 2023	526.01M	-203.61M	-27.91%
Dec 31, 2022	729.61M	135.35M	22.78%
Dec 31, 2021	594.26M	163.76M	38.04%
Dec 31, 2020	430.50M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Commercial International Bank Egypt (CIB) S.A.E.	107.76B
El Sewedy Electric Company	246.12B
Talaat Moustafa Group Holding	45.30B
Eastern Company S.A.E	34.08B
Misr Fertilizer Production Company	21.20B
Alexandria Container&Cargo Handling Company	8.41B
Egypt Aluminum	42.42B
Telecom Egypt Company	89.35B

Revenue Rankings